Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754260 · ClinicalTrials.gov registry record · NA
Caffeine Reduction and Overactive Bladder Symptoms
A NA study, sponsored by University of New Mexico.
- Terminated
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00754260 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 42 participants.
The verdict
NCT00754260, a NA study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
A. Statement of Objective: To conduct a randomized trial to evaluate the impact of caffeine restriction on Overactive Bladder(OAB) symptoms including urinary frequency, nocturia, incontinence episodes, symptom severity and bother and quality of life. B. Specific Aims/Hypothesis: 1. To determine if reduction in caffeine intake decreases urinary frequency, nocturia and incontinence episodes as measured on a 3-day voiding diary in women with Overactive Bladder (OAB). We hypothesize that women with overactive bladder will report less frequent urination and decreased nocturia and incontinence episodes with caffeine reduction. 2. To determine whether caffeine reduction results in decreased symptom severity and bother and improved quality of life scores as measured by the Questionnaire for Incontinence Severity Index (ISI), Questionnaire for Urinary Incontinence Diagnosis (QUID), Urogenital Distress Inventory (UDI-6) and the Incontinence Impact Questionnaire (IIQ-7). We hypothesize that women with OAB who reduce their intake of caffeine will report decreased symptom bother and improved quality of life as measured by the ISI, UDI-6 and the IIQ-
Interventions
- BEHAVIORAL Caffeine reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754260
The ClinicalTrials.gov registry entry for NCT00754260 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Caffeine reduction is the first listed.
NCT00754260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00754260 about?
NCT00754260 is a clinical study titled "Caffeine Reduction and Overactive Bladder Symptoms". A. Statement of Objective: To conduct a randomized trial to evaluate the impact of caffeine restriction on Overactive Bladder(OAB) symptoms including urinary frequency, nocturia, incontinence episodes, symptom severity and bother and quality of life. B. Specific Aims/Hypothesis: 1. To determine if...
What is the current status of trial NCT00754260?
This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2008-03. Estimated completion is 2009-06-30.
What interventions are being tested in trial NCT00754260?
The interventions under investigation include: Caffeine reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT00754260?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.